Prospective, observational study in sickle cell disease patients on crizanlizumab treatment in Middle East countries and India.
عنوان الدراسة
Prospective, observational study in sickle cell disease patients on crizanlizumab treatment in Middle East countries and India.
داعم الدراسة
Novartis
دواء الدراسة
crizanlizumab
رقم بروتوكول الدراسة
CSEG101AIC05
حالة الدراسة
Ongoing
موقع الدراسة
Prince Mohammad Bin Naser Hospital, Jizan, Saudi Arabia
مرحلة الدراسة
4
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.